Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol 40 mg for fear conditioning and extinction in healthy adults
NL-OMON42213Active, not recruiting
- Sponsor
- Utrecht University
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of cannabidiol in anxiety disorder and specific phobia (2 arms), sponsored by Utrecht University. Primary endpoints: Fear response measured by EMG and Fear response measured by visual analogue scale. Started Sep 2015; status: active, not recruiting.
02
Drugs
cannabidiol
03
Conditions
anxiety disorderspecific phobia
Beyond the preview
Go deeper on NL-OMON42213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42213.